BENEFITS OF THROMBOLYSIS BEFORE HOSPITALIZATION FOR ACUTE CORONARY SYNDROME
Ключевые слова:
myocardial infarction, thrombolysis, fibrinolyticsАннотация
The review describes the features of thrombolytic therapy in patients with acute myocardial infarction in detail. Thrombolytic therapy helps to reduce 30-day mortality in myocardial infarction from 17-18% to 5-8%. The issues of the optimal period of thrombolysis from the onset of the clinical manifestations of a heart attack, alternative methods for restoring coronary blood flow, indications and contraindications, complications and side effects, and methods for evaluating the effectiveness of thrombolysis are highlighted. The main fibrin-selective and fibrin-non-selective fibrinolytic drugs: streptokinase, alteplase, tenecteplase are listed. The results of large randomized clinical trials on fibrinolytic therapy of myocardial infarction are presented. The possibilities of increasing the effectiveness and safety of fibrinolytics by combining them with acetylsalicylic acid and heparins are discussed.
Библиографические ссылки
Antman E.M. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines, for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee/ Antman E.M., Hand M., Armstrong P.W, [et al] // Circulation. - 2008. -Vol. 117. - P.296-329
Armstrong P., WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study/ Armstrong P. // Eur Heart J. -2006. - Vol.27. -P.1530-1538.
Bjorklund E. Prehospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patents with ST-elevation myocardial infarction / Bjorklund E., Stenestrand U., Lindback J., et al on behalf of the RIKS-HIA Investigators // Eur Heart J. - 2006. -Vol.27 - P.1146-1152.
Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction / Boersma E., the PCAT-2 Trialists' Collaborative Group //Eur Heart J. - 2006 - Vol.27 - P.779-788.
